| 198 | 17 | 15 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:探讨DPP-4抑制剂联合二甲双胍对2型糖尿病合并代谢综合征患者糖脂代谢、微炎症状态的影响。方法:选择在我科接受治疗的2型糖尿病合并代谢综合征患者60例,随机分为对照组、观察组各30例。对照组接受单独二甲双胍治疗,观察组接受DPP-4抑制剂联合二甲双胍治疗,对比两组的治疗前后糖脂代谢指标、炎症因子水平的差异。结果:治疗前,两组外周血中糖脂代谢指标水平、血清中炎症因子含量的差异无统计学意义(P>0.05)。治疗后,观察组外周血中糖代谢指标FPG、FPI、HOMA-IR的及脂质代谢指标TG、TC的含量低于对照组,HDL-C的含量高于对照组;血清中炎症因子IL-6、CRP、TNF-α的含量低于对照组(P<0.05)。结论:2型糖尿病合并代谢综合征患者接受DPP-4抑制剂联合二甲双胍治疗,能够更为有效的控制机体糖脂代谢进程,并抑制微炎症状态。
Abstract：Objective:To study the effect of DPP-4 inhibitor combined with metformin on glucose and lipid metabolism and micro-inflammatory state in patients with type 2 diabetes mellitus complicated by metabolic syndrome.Methods:60 patients with type 2 diabetes mellitus complicated by metabolic syndrome who were treated in the hospital between February 2015 and December 2016 were divided into control group(n=30)and observation group(n=30)according to the random number table method.Control group received metformin therapy alone,observation group received DPP-4 inhibitor combined with metformin therapy,and the differences in levels of glucose and lipid metabolism indexes and inflammatory factors were compared between the two groups of patients before and after treatment.Results:Before treatment,the differences in glucose and lipid metabolism index levels in peripheral blood as well as inflammatory factor contents in serum were not statistically significant between the two groups(P>0.05).After treatment,the levels of glucose metabolism indexes FPG,FPI and HOMA-IR as well as lipid metabolism indexes TG and TC in peripheral blood of observation group were lower than those of control group while HDL-C level was higher than that of control group;the contents of inflammatory factors IL-6,CRP and TNF-αin serum were lower than those of control group(P<0.05).Conclusion:DPP-4 inhibitor combined with metformin therapy is more effective in controlling the glucose and lipid metabolism process and inhibiting the micro-inflammatory state in patients with type2 diabetes mellitus complicated by metabolic syndrome.
1 Borja MS,Hammerson B,Tang C,et al.Apolipoprotein A-I exchange is impaired in metabolic syndrome patients asymptomatic fordiabetes and cardiovascular disease[J].PLoS One,2017,12(8):e0182217.
2 Tang XN,Liebeskind DS,Towfighi A.The Role of Diabetes,Obesity,and Metabolic Syndrome in Stroke[J].SeminNeurol,2017,37(3):267-273.
3 vanOtterdijk SD,Binder AM,SzarcVelSzic K,et al.DNA methylation of candidate genes in peripheral blood from patients with type 2diabetes or themetabolic syndrome[J].PLoS One,2017,12(7):e0180955.
4 Zawiejska A,Wender-Ozegowska E,Grewling-Szmit K,et al.Short-term antidiabetic treatment with insulin or metformin has a similar impact on the components of metabolic syndrome in women with gestational diabetes mellitus requiring antidiabetic agents:results of a prospective,randomised study[J].J PhysiolPharmacol,2016,67(2):227-233.
5 Sicras-Mainar A,Navarro-Artieda R.Healthcare costs of the combination of metformin/dipeptidyl peptidase-4 inhibitors compared withmetformin/other oral antidiabetes agents in patients with type 2diabetes and metabolic syndrome[J].Diabetes TechnolTher,2014,16(11):722-727.
6 Chin HJ,Nam JH,Lee EK,et al.Comparative safety for cardiovascular outcomes of DPP-4inhibitors versus glimepiride in patients with type 2diabetes:A retrospective cohort study[J].Medicine(Baltimore),2017,96(25):e7213.
7 Munir KM,Lamos EM.Diabetes type 2management:what are the differences between DPP-4 inhibitors and how do you choose?[J].Expert OpinPharmacother,2017,18(9):839-841.
8 Medeiros RF,Gaique TG,Bento-Bernardes T,et al.Arginine and aerobic training prevent endothelial and metabolic alterations in rats at high risk for the development of the metabolic syndrome[J].Br J Nutr,2017,118(1):1-10.
9 Ma MCJ,Pettus JM,Jakoubek JA,et al.Contribution of independent and pleiotropic genetic effects in the metabolic syndrome in a hypertensive rat[J].PLoS One,2017,12(8):e0182650.
10 Srinivasa S,Wong K,Fitch KV,et al.Effects of lifestyle modification and metformin on irisin and FGF21among HIV-infected subjects with the metabolic syndrome[J].ClinEndocrinol(Oxf),2015,82(5):678-685.
11 Cahn A,Cernea S,Raz I.An update on DPP-4inhibitors in the management of type 2diabetes[J].Expert OpinEmerg Drugs,2016,21(4):409-419.
12 Wu WL,Hao J,Domalski M,et al.Discovery of Novel Tricyclic Heterocycles as Potent and Selective DPP-4Inhibitors for the Treatment of Type 2 Diabetes[J].ACS Med ChemLett,2016,7(5):498-501.
13 Song AQ,Sun LR,Zhao YX,et al.Effect of insulin and metformin on methylation and glycolipid metabolism of peroxisome proliferator-activated receptorγcoactivator-1Aof rat offspring with gestational diabetes mellitus[J].Asian Pac J Trop Med,2016,9(1):91-95.
14 Liu Y,Liu SX,Cai Y,et al.Effects of combined aerobic and resistance training on the glycolipid metabolism and inflammation levels in type 2diabetes mellitus[J].J PhysTherSci,2015,27(7):2365-2371.
15 Nian X,Zhang X,Wang Y,et al.Correlations of FOXC2Gene Expression and Polymorphism with Type 2 Diabetes Mellitus[J].Clin Lab,2016,62(5):781-791.
16 Lee JY,Kim MY,Shin SH,et al.Persicarin isolated from Oenanthe javanica protects against diabetes-induced oxidative stress and inflammation in the liver of streptozotocin-induced type 1diabetic mice[J].ExpTher Med,2017,13(4):1194-1202.
17 Chávez-Talavera O,Tailleux A,Lefebvre P,et al.Bile Acid Control of Metabolism and Inflammation in Obesity,Type 2Diabetes,Dyslipidemia,and Nonalcoholic Fatty Liver Disease[J].Gastroenterology,2017,152(7):1679-1694.
18 Jiang X,Zhou Y,Wu KK,et al.APPL1prevents pancreatic beta cell death and inflammation by dampening NFκB activation in a mouse model of type 1diabetes[J].Diabetologia,2017,60(3):464-474.
19 Markova M,Pivovarova O,Hornemann S,et al.Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2Diabetes[J].Gastroenterology,2017,152(3):571-585.
20 Durning SP,Preston-Hurlburt P,Clark PR,et al.The Receptor for Advanced Glycation Endproducts Drives T Cell Survival and Inflammation in Type 1Diabetes Mellitus[J].J Immunol,2016,197(8):3076-3085.
21 Kelany ME,Hakami TM,Omar AH,et al.Combination of Sitagliptin and Insulin against Type 2 Diabetes Mellitus with Neuropathy in Rats:Neuroprotection and Role of Oxidative and Inflammation Stress[J].Pharmacology,2016,98(5-6):242-250.
基本信息:
DOI：10.13210/j.cnki.jhmu.20170928.004
中图分类号:R587.1;R589
引用信息:
[1]严小宏,卢勇.DPP-4抑制剂联合二甲双胍对2型糖尿病合并代谢综合征患者糖脂代谢、微炎症状态的影响[J].海南医学院学报,2017,23(19):2623-2626.DOI:10.13210/j.cnki.jhmu.20170928.004.
基金信息:
2013湖北省卫计委面上项目(JX6B105)~~
2017-09-28
2017-09-28
2017-09-28